Cancer Registry Software Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Standalone Software, Integrated Software); Deployment Model (On-Premise Models, Cloud-Based Models); Database Type (Commercial Database, Public Databases); Functionality (Cancer Reporting to Meet State and Federal Regulations, Patient Care Management, Medical Research and Clinical Studies, Product Outcome Evaluation); End User (Government Organizations and Third Party Administrators, Hospitals and Medical Practices, Private Players, Pharmaceutical, Biotechnology and Medical Device Companies, Research Centers.) and Geography

Report Code: TIPRE00003995 | No. of Pages: 150 | Category: Healthcare IT | Status: Upcoming

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!
MARKET OVERVIEW

Cancer Registry Software is a type of disease registry that is primarily used to set up and maintain a system for reporting cancer incidence. The cancer registry system serves as a data source for researchers looking into cancer and its causes. This type of registry is significant because cancer is one of the leading causes of death, therefore collecting data on cancer cases from diagnosis to survivorship is beneficial in order to identify trends and, ultimately, improve care for cancer patients.

MARKET SCOPE

The "Global Cancer Registry Software Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the cancer registry software market with detailed market segmentation by type, deployment model, database type, functionality and end user. The report provides key statistics on the market status of the leading cancer registry software market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

  •   Based on type the market is segmented as, Standalone Software and Integrated Software.
  •   Based on deployment model the market is segmented as, On-Premise Models and Cloud-Based Models.
  •   Based on database type the market is segmented as, Commercial Database and Public Databases.
  •   Based on functionality the market is segmented as, Cancer Reporting to Meet State and Federal Regulations, Patient Care Management, Medical Research & Clinical Studies and Product Outcome Evaluation.
  •   Based on end user the market is segmented as, Government Organizations & Third Party Administrators, Hospitals & Medical Practices, Private Players, Pharmaceutical, Biotechnology and Medical Device Companies and Research Centers.

MARKET DYNAMICS
Drivers:

  •   Growing prevalence of cancers across the globe is the key driving factor for the market growth.
  •   Increasing pressure to improve quality of care and reducing total healthcare costs.
  •   Increasing adoption of EHRs is also expected to spur the market growth.
  •   Increasing adoption of cancer registry for post market survellience.

Restraints:

  •   However, issues such as, privacy and security issues are likely to restrain market growth during the forecast period.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The cancer registry software market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the cancer registry software market in these regions.

IMPACT OF COVID-19ON CANCER REGISTRY SOFTWARE MARKET

COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS

The report covers key developments in the cancer registry software market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from cancer registry software market are anticipated to lucrative growth opportunities in the future with the rising demand for cancer registry software in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the cancer registry software market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Onco, Inc
  •   C/Net Solutions
  •   Elekta AB
  •   Rocky Mountain Cancer Data Systems
  •   NeuralFrame, Inc
  •   Mckesson Corporation
  •   Ordinal Data, Inc
  •   Conduent, Inc
  •   IBM
  •   himagine solutions
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cancer Registry Software Market - By Type
1.3.2 Cancer Registry Software Market - By Deployment Model
1.3.3 Cancer Registry Software Market - By Database Type
1.3.4 Cancer Registry Software Market - By Functionality
1.3.5 Cancer Registry Software Market - By End User
1.3.6 Cancer Registry Software Market - By Region
1.3.6.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. CANCER REGISTRY SOFTWARE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. CANCER REGISTRY SOFTWARE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. CANCER REGISTRY SOFTWARE MARKET - GLOBAL MARKET ANALYSIS
6.1. CANCER REGISTRY SOFTWARE - GLOBAL MARKET OVERVIEW
6.2. CANCER REGISTRY SOFTWARE - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE

7. CANCER REGISTRY SOFTWARE MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. STANDALONE SOFTWARE
7.3.1. Overview
7.3.2. Standalone Software Market Forecast and Analysis
7.4. INTEGRATED SOFTWARE
7.4.1. Overview
7.4.2. Integrated Software Market Forecast and Analysis
8. CANCER REGISTRY SOFTWARE MARKET - REVENUE AND FORECASTS TO 2028 - DEPLOYMENT MODEL
8.1. OVERVIEW
8.2. DEPLOYMENT MODEL MARKET FORECASTS AND ANALYSIS
8.3. ON-PREMISE MODELS
8.3.1. Overview
8.3.2. On-Premise Models Market Forecast and Analysis
8.4. CLOUD-BASED MODELS
8.4.1. Overview
8.4.2. Cloud-Based Models Market Forecast and Analysis
9. CANCER REGISTRY SOFTWARE MARKET - REVENUE AND FORECASTS TO 2028 - DATABASE TYPE
9.1. OVERVIEW
9.2. DATABASE TYPE MARKET FORECASTS AND ANALYSIS
9.3. COMMERCIAL DATABASE
9.3.1. Overview
9.3.2. Commercial Database Market Forecast and Analysis
9.4. PUBLIC DATABASES
9.4.1. Overview
9.4.2. Public Databases Market Forecast and Analysis
10. CANCER REGISTRY SOFTWARE MARKET - REVENUE AND FORECASTS TO 2028 - FUNCTIONALITY
10.1. OVERVIEW
10.2. FUNCTIONALITY MARKET FORECASTS AND ANALYSIS
10.3. CANCER REPORTING TO MEET STATE AND FEDERAL REGULATIONS
10.3.1. Overview
10.3.2. Cancer Reporting to Meet State and Federal Regulations Market Forecast and Analysis
10.4. PATIENT CARE MANAGEMENT
10.4.1. Overview
10.4.2. Patient Care Management Market Forecast and Analysis
10.5. MEDICAL RESEARCH AND CLINICAL STUDIES
10.5.1. Overview
10.5.2. Medical Research and Clinical Studies Market Forecast and Analysis
10.6. PRODUCT OUTCOME EVALUATION
10.6.1. Overview
10.6.2. Product Outcome Evaluation Market Forecast and Analysis
11. CANCER REGISTRY SOFTWARE MARKET - REVENUE AND FORECASTS TO 2028 - END USER
11.1. OVERVIEW
11.2. END USER MARKET FORECASTS AND ANALYSIS
11.3. GOVERNMENT ORGANIZATIONS AND THIRD PARTY ADMINISTRATORS
11.3.1. Overview
11.3.2. Government Organizations and Third Party Administrators Market Forecast and Analysis
11.4. HOSPITALS AND MEDICAL PRACTICES
11.4.1. Overview
11.4.2. Hospitals and Medical Practices Market Forecast and Analysis
11.5. PRIVATE PLAYERS
11.5.1. Overview
11.5.2. Private Players Market Forecast and Analysis
11.6. PHARMACEUTICAL
11.6.1. Overview
11.6.2. Pharmaceutical Market Forecast and Analysis
11.7. BIOTECHNOLOGY AND MEDICAL DEVICE COMPANIES
11.7.1. Overview
11.7.2. Biotechnology and Medical Device Companies Market Forecast and Analysis
11.8. RESEARCH CENTERS.
11.8.1. Overview
11.8.2. Research Centers. Market Forecast and Analysis

12. CANCER REGISTRY SOFTWARE MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
12.1. NORTH AMERICA
12.1.1 North America Cancer Registry Software Market Overview
12.1.2 North America Cancer Registry Software Market Forecasts and Analysis
12.1.3 North America Cancer Registry Software Market Forecasts and Analysis - By Type
12.1.4 North America Cancer Registry Software Market Forecasts and Analysis - By Deployment Model
12.1.5 North America Cancer Registry Software Market Forecasts and Analysis - By Database Type
12.1.6 North America Cancer Registry Software Market Forecasts and Analysis - By Functionality
12.1.7 North America Cancer Registry Software Market Forecasts and Analysis - By End User
12.1.8 North America Cancer Registry Software Market Forecasts and Analysis - By Countries
12.1.8.1 United States Cancer Registry Software Market
12.1.8.1.1 United States Cancer Registry Software Market by Type
12.1.8.1.2 United States Cancer Registry Software Market by Deployment Model
12.1.8.1.3 United States Cancer Registry Software Market by Database Type
12.1.8.1.4 United States Cancer Registry Software Market by Functionality
12.1.8.1.5 United States Cancer Registry Software Market by End User
12.1.8.2 Canada Cancer Registry Software Market
12.1.8.2.1 Canada Cancer Registry Software Market by Type
12.1.8.2.2 Canada Cancer Registry Software Market by Deployment Model
12.1.8.2.3 Canada Cancer Registry Software Market by Database Type
12.1.8.2.4 Canada Cancer Registry Software Market by Functionality
12.1.8.2.5 Canada Cancer Registry Software Market by End User
12.1.8.3 Mexico Cancer Registry Software Market
12.1.8.3.1 Mexico Cancer Registry Software Market by Type
12.1.8.3.2 Mexico Cancer Registry Software Market by Deployment Model
12.1.8.3.3 Mexico Cancer Registry Software Market by Database Type
12.1.8.3.4 Mexico Cancer Registry Software Market by Functionality
12.1.8.3.5 Mexico Cancer Registry Software Market by End User
12.2. EUROPE
12.2.1 Europe Cancer Registry Software Market Overview
12.2.2 Europe Cancer Registry Software Market Forecasts and Analysis
12.2.3 Europe Cancer Registry Software Market Forecasts and Analysis - By Type
12.2.4 Europe Cancer Registry Software Market Forecasts and Analysis - By Deployment Model
12.2.5 Europe Cancer Registry Software Market Forecasts and Analysis - By Database Type
12.2.6 Europe Cancer Registry Software Market Forecasts and Analysis - By Functionality
12.2.7 Europe Cancer Registry Software Market Forecasts and Analysis - By End User
12.2.8 Europe Cancer Registry Software Market Forecasts and Analysis - By Countries
12.2.8.1 Germany Cancer Registry Software Market
12.2.8.1.1 Germany Cancer Registry Software Market by Type
12.2.8.1.2 Germany Cancer Registry Software Market by Deployment Model
12.2.8.1.3 Germany Cancer Registry Software Market by Database Type
12.2.8.1.4 Germany Cancer Registry Software Market by Functionality
12.2.8.1.5 Germany Cancer Registry Software Market by End User
12.2.8.2 France Cancer Registry Software Market
12.2.8.2.1 France Cancer Registry Software Market by Type
12.2.8.2.2 France Cancer Registry Software Market by Deployment Model
12.2.8.2.3 France Cancer Registry Software Market by Database Type
12.2.8.2.4 France Cancer Registry Software Market by Functionality
12.2.8.2.5 France Cancer Registry Software Market by End User
12.2.8.3 Italy Cancer Registry Software Market
12.2.8.3.1 Italy Cancer Registry Software Market by Type
12.2.8.3.2 Italy Cancer Registry Software Market by Deployment Model
12.2.8.3.3 Italy Cancer Registry Software Market by Database Type
12.2.8.3.4 Italy Cancer Registry Software Market by Functionality
12.2.8.3.5 Italy Cancer Registry Software Market by End User
12.2.8.4 Spain Cancer Registry Software Market
12.2.8.4.1 Spain Cancer Registry Software Market by Type
12.2.8.4.2 Spain Cancer Registry Software Market by Deployment Model
12.2.8.4.3 Spain Cancer Registry Software Market by Database Type
12.2.8.4.4 Spain Cancer Registry Software Market by Functionality
12.2.8.4.5 Spain Cancer Registry Software Market by End User
12.2.8.5 United Kingdom Cancer Registry Software Market
12.2.8.5.1 United Kingdom Cancer Registry Software Market by Type
12.2.8.5.2 United Kingdom Cancer Registry Software Market by Deployment Model
12.2.8.5.3 United Kingdom Cancer Registry Software Market by Database Type
12.2.8.5.4 United Kingdom Cancer Registry Software Market by Functionality
12.2.8.5.5 United Kingdom Cancer Registry Software Market by End User
12.2.8.6 Rest of Europe Cancer Registry Software Market
12.2.8.6.1 Rest of Europe Cancer Registry Software Market by Type
12.2.8.6.2 Rest of Europe Cancer Registry Software Market by Deployment Model
12.2.8.6.3 Rest of Europe Cancer Registry Software Market by Database Type
12.2.8.6.4 Rest of Europe Cancer Registry Software Market by Functionality
12.2.8.6.5 Rest of Europe Cancer Registry Software Market by End User
12.3. ASIA-PACIFIC
12.3.1 Asia-Pacific Cancer Registry Software Market Overview
12.3.2 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis
12.3.3 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By Type
12.3.4 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By Deployment Model
12.3.5 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By Database Type
12.3.6 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By Functionality
12.3.7 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By End User
12.3.8 Asia-Pacific Cancer Registry Software Market Forecasts and Analysis - By Countries
12.3.8.1 Australia Cancer Registry Software Market
12.3.8.1.1 Australia Cancer Registry Software Market by Type
12.3.8.1.2 Australia Cancer Registry Software Market by Deployment Model
12.3.8.1.3 Australia Cancer Registry Software Market by Database Type
12.3.8.1.4 Australia Cancer Registry Software Market by Functionality
12.3.8.1.5 Australia Cancer Registry Software Market by End User
12.3.8.2 China Cancer Registry Software Market
12.3.8.2.1 China Cancer Registry Software Market by Type
12.3.8.2.2 China Cancer Registry Software Market by Deployment Model
12.3.8.2.3 China Cancer Registry Software Market by Database Type
12.3.8.2.4 China Cancer Registry Software Market by Functionality
12.3.8.2.5 China Cancer Registry Software Market by End User
12.3.8.3 India Cancer Registry Software Market
12.3.8.3.1 India Cancer Registry Software Market by Type
12.3.8.3.2 India Cancer Registry Software Market by Deployment Model
12.3.8.3.3 India Cancer Registry Software Market by Database Type
12.3.8.3.4 India Cancer Registry Software Market by Functionality
12.3.8.3.5 India Cancer Registry Software Market by End User
12.3.8.4 Japan Cancer Registry Software Market
12.3.8.4.1 Japan Cancer Registry Software Market by Type
12.3.8.4.2 Japan Cancer Registry Software Market by Deployment Model
12.3.8.4.3 Japan Cancer Registry Software Market by Database Type
12.3.8.4.4 Japan Cancer Registry Software Market by Functionality
12.3.8.4.5 Japan Cancer Registry Software Market by End User
12.3.8.5 South Korea Cancer Registry Software Market
12.3.8.5.1 South Korea Cancer Registry Software Market by Type
12.3.8.5.2 South Korea Cancer Registry Software Market by Deployment Model
12.3.8.5.3 South Korea Cancer Registry Software Market by Database Type
12.3.8.5.4 South Korea Cancer Registry Software Market by Functionality
12.3.8.5.5 South Korea Cancer Registry Software Market by End User
12.3.8.6 Rest of Asia-Pacific Cancer Registry Software Market
12.3.8.6.1 Rest of Asia-Pacific Cancer Registry Software Market by Type
12.3.8.6.2 Rest of Asia-Pacific Cancer Registry Software Market by Deployment Model
12.3.8.6.3 Rest of Asia-Pacific Cancer Registry Software Market by Database Type
12.3.8.6.4 Rest of Asia-Pacific Cancer Registry Software Market by Functionality
12.3.8.6.5 Rest of Asia-Pacific Cancer Registry Software Market by End User
12.4. MIDDLE EAST AND AFRICA
12.4.1 Middle East and Africa Cancer Registry Software Market Overview
12.4.2 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis
12.4.3 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By Type
12.4.4 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By Deployment Model
12.4.5 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By Database Type
12.4.6 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By Functionality
12.4.7 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By End User
12.4.8 Middle East and Africa Cancer Registry Software Market Forecasts and Analysis - By Countries
12.4.8.1 South Africa Cancer Registry Software Market
12.4.8.1.1 South Africa Cancer Registry Software Market by Type
12.4.8.1.2 South Africa Cancer Registry Software Market by Deployment Model
12.4.8.1.3 South Africa Cancer Registry Software Market by Database Type
12.4.8.1.4 South Africa Cancer Registry Software Market by Functionality
12.4.8.1.5 South Africa Cancer Registry Software Market by End User
12.4.8.2 Saudi Arabia Cancer Registry Software Market
12.4.8.2.1 Saudi Arabia Cancer Registry Software Market by Type
12.4.8.2.2 Saudi Arabia Cancer Registry Software Market by Deployment Model
12.4.8.2.3 Saudi Arabia Cancer Registry Software Market by Database Type
12.4.8.2.4 Saudi Arabia Cancer Registry Software Market by Functionality
12.4.8.2.5 Saudi Arabia Cancer Registry Software Market by End User
12.4.8.3 U.A.E Cancer Registry Software Market
12.4.8.3.1 U.A.E Cancer Registry Software Market by Type
12.4.8.3.2 U.A.E Cancer Registry Software Market by Deployment Model
12.4.8.3.3 U.A.E Cancer Registry Software Market by Database Type
12.4.8.3.4 U.A.E Cancer Registry Software Market by Functionality
12.4.8.3.5 U.A.E Cancer Registry Software Market by End User
12.4.8.4 Rest of Middle East and Africa Cancer Registry Software Market
12.4.8.4.1 Rest of Middle East and Africa Cancer Registry Software Market by Type
12.4.8.4.2 Rest of Middle East and Africa Cancer Registry Software Market by Deployment Model
12.4.8.4.3 Rest of Middle East and Africa Cancer Registry Software Market by Database Type
12.4.8.4.4 Rest of Middle East and Africa Cancer Registry Software Market by Functionality
12.4.8.4.5 Rest of Middle East and Africa Cancer Registry Software Market by End User
12.5. SOUTH AND CENTRAL AMERICA
12.5.1 South and Central America Cancer Registry Software Market Overview
12.5.2 South and Central America Cancer Registry Software Market Forecasts and Analysis
12.5.3 South and Central America Cancer Registry Software Market Forecasts and Analysis - By Type
12.5.4 South and Central America Cancer Registry Software Market Forecasts and Analysis - By Deployment Model
12.5.5 South and Central America Cancer Registry Software Market Forecasts and Analysis - By Database Type
12.5.6 South and Central America Cancer Registry Software Market Forecasts and Analysis - By Functionality
12.5.7 South and Central America Cancer Registry Software Market Forecasts and Analysis - By End User
12.5.8 South and Central America Cancer Registry Software Market Forecasts and Analysis - By Countries
12.5.8.1 Brazil Cancer Registry Software Market
12.5.8.1.1 Brazil Cancer Registry Software Market by Type
12.5.8.1.2 Brazil Cancer Registry Software Market by Deployment Model
12.5.8.1.3 Brazil Cancer Registry Software Market by Database Type
12.5.8.1.4 Brazil Cancer Registry Software Market by Functionality
12.5.8.1.5 Brazil Cancer Registry Software Market by End User
12.5.8.2 Argentina Cancer Registry Software Market
12.5.8.2.1 Argentina Cancer Registry Software Market by Type
12.5.8.2.2 Argentina Cancer Registry Software Market by Deployment Model
12.5.8.2.3 Argentina Cancer Registry Software Market by Database Type
12.5.8.2.4 Argentina Cancer Registry Software Market by Functionality
12.5.8.2.5 Argentina Cancer Registry Software Market by End User
12.5.8.3 Rest of South and Central America Cancer Registry Software Market
12.5.8.3.1 Rest of South and Central America Cancer Registry Software Market by Type
12.5.8.3.2 Rest of South and Central America Cancer Registry Software Market by Deployment Model
12.5.8.3.3 Rest of South and Central America Cancer Registry Software Market by Database Type
12.5.8.3.4 Rest of South and Central America Cancer Registry Software Market by Functionality
12.5.8.3.5 Rest of South and Central America Cancer Registry Software Market by End User

13. INDUSTRY LANDSCAPE
13.1. MERGERS AND ACQUISITIONS
13.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
13.3. NEW PRODUCT LAUNCHES
13.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

14. CANCER REGISTRY SOFTWARE MARKET, KEY COMPANY PROFILES
14.1. ONCO, INC
14.1.1. Key Facts
14.1.2. Business Description
14.1.3. Products and Services
14.1.4. Financial Overview
14.1.5. SWOT Analysis
14.1.6. Key Developments
14.2. C/NET SOLUTIONS
14.2.1. Key Facts
14.2.2. Business Description
14.2.3. Products and Services
14.2.4. Financial Overview
14.2.5. SWOT Analysis
14.2.6. Key Developments
14.3. ELEKTA AB
14.3.1. Key Facts
14.3.2. Business Description
14.3.3. Products and Services
14.3.4. Financial Overview
14.3.5. SWOT Analysis
14.3.6. Key Developments
14.4. ROCKY MOUNTAIN CANCER DATA SYSTEMS
14.4.1. Key Facts
14.4.2. Business Description
14.4.3. Products and Services
14.4.4. Financial Overview
14.4.5. SWOT Analysis
14.4.6. Key Developments
14.5. NEURALFRAME, INC
14.5.1. Key Facts
14.5.2. Business Description
14.5.3. Products and Services
14.5.4. Financial Overview
14.5.5. SWOT Analysis
14.5.6. Key Developments
14.6. MCKESSON CORPORATION
14.6.1. Key Facts
14.6.2. Business Description
14.6.3. Products and Services
14.6.4. Financial Overview
14.6.5. SWOT Analysis
14.6.6. Key Developments
14.7. ORDINAL DATA, INC
14.7.1. Key Facts
14.7.2. Business Description
14.7.3. Products and Services
14.7.4. Financial Overview
14.7.5. SWOT Analysis
14.7.6. Key Developments
14.8. CONDUENT, INC
14.8.1. Key Facts
14.8.2. Business Description
14.8.3. Products and Services
14.8.4. Financial Overview
14.8.5. SWOT Analysis
14.8.6. Key Developments
14.9. IBM
14.9.1. Key Facts
14.9.2. Business Description
14.9.3. Products and Services
14.9.4. Financial Overview
14.9.5. SWOT Analysis
14.9.6. Key Developments
14.10. HIMAGINE SOLUTIONS
14.10.1. Key Facts
14.10.2. Business Description
14.10.3. Products and Services
14.10.4. Financial Overview
14.10.5. SWOT Analysis
14.10.6. Key Developments

15. APPENDIX
15.1. ABOUT THE INSIGHT PARTNERS
15.2. GLOSSARY OF TERMS
The List of Companies

1. Onco, Inc
2. C/Net Solutions
3. Elekta AB
4. Rocky Mountain Cancer Data Systems
5. NeuralFrame, Inc
6. Mckesson Corporation
7. Ordinal Data, Inc
8. Conduent, Inc
9. IBM
10. himagine solutions
TIPRE00003995
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking